182 related articles for article (PubMed ID: 23257757)
1. [A comparative evaluation of the efficacy of valdoxan (agomelatine) in recurrent depression and bipolar affective disorder].
Tiuvina NA; Smirnova VN
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(11 Pt 2):53-60. PubMed ID: 23257757
[TBL] [Abstract][Full Text] [Related]
2. Superior antidepressant efficacy results of agomelatine versus fluoxetine in severe MDD patients: a randomized, double-blind study.
Hale A; Corral RM; Mencacci C; Ruiz JS; Severo CA; Gentil V
Int Clin Psychopharmacol; 2010 Nov; 25(6):305-14. PubMed ID: 20856123
[TBL] [Abstract][Full Text] [Related]
3. Agomelatine in the treatment of seasonal affective disorder.
Pjrek E; Winkler D; Konstantinidis A; Willeit M; Praschak-Rieder N; Kasper S
Psychopharmacology (Berl); 2007 Mar; 190(4):575-9. PubMed ID: 17171557
[TBL] [Abstract][Full Text] [Related]
4. A placebo-controlled study of three agomelatine dose regimens (10 mg, 25 mg, 25-50 mg) in patients with major depressive disorder.
Kennedy SH; Avedisova A; Giménez-Montesinos N; Belaïdi C; de Bodinat C;
Eur Neuropsychopharmacol; 2014 Apr; 24(4):553-63. PubMed ID: 24530273
[TBL] [Abstract][Full Text] [Related]
5. The mechanism, efficacy, and tolerability profile of agomelatine.
MacIsaac SE; Carvalho AF; Cha DS; Mansur RB; McIntyre RS
Expert Opin Pharmacother; 2014 Feb; 15(2):259-74. PubMed ID: 24328686
[TBL] [Abstract][Full Text] [Related]
6. Beyond the monoaminergic hypothesis: agomelatine, a new antidepressant with an innovative mechanism of action.
Kasper S; Hamon M
World J Biol Psychiatry; 2009; 10(2):117-26. PubMed ID: 19255935
[TBL] [Abstract][Full Text] [Related]
7. Major depression is sometimes described as the common cold of psychiatry.
Goodwin GM
J Psychopharmacol; 2008 Sep; 22(7 Suppl):3. PubMed ID: 18753275
[No Abstract] [Full Text] [Related]
8. Melatonin receptor agonist agomelatine: a new drug for treating unipolar depression.
Bourin M; Prica C
Curr Pharm Des; 2009; 15(14):1675-82. PubMed ID: 19442180
[TBL] [Abstract][Full Text] [Related]
9. Evidence of agomelatine's antidepressant efficacy: the key points.
Eser D; Baghai TC; Möller HJ
Int Clin Psychopharmacol; 2007 Oct; 22 Suppl 2():S15-9. PubMed ID: 17917562
[TBL] [Abstract][Full Text] [Related]
10. Agomelatine: efficacy at each phase of antidepressant treatment.
Kennedy SH
CNS Drugs; 2009; 23 Suppl 2():41-7. PubMed ID: 19708725
[TBL] [Abstract][Full Text] [Related]
11. Addressing circadian rhythm disturbances in depressed patients.
Lam RW
J Psychopharmacol; 2008 Sep; 22(7 Suppl):13-8. PubMed ID: 18753278
[TBL] [Abstract][Full Text] [Related]
12. Innovation translates into antidepressant effectiveness.
Goodwin GM
J Psychopharmacol; 2008 Sep; 22(7 Suppl):9-12. PubMed ID: 18753277
[TBL] [Abstract][Full Text] [Related]
13. Treating each and every depressed patient.
Kennedy SH
J Psychopharmacol; 2008 Sep; 22(7 Suppl):19-23. PubMed ID: 18753279
[TBL] [Abstract][Full Text] [Related]
14. Agomelatine, an innovative pharmacological response to unmet needs.
Le Strat Y; Gorwood P
J Psychopharmacol; 2008 Sep; 22(7 Suppl):4-8. PubMed ID: 18753276
[TBL] [Abstract][Full Text] [Related]
15. [Possibilities of preventive treatment of migraine with the MT1- and MT2 agonist and 5-HT2с receptor antagonist agomelatin (valdoxan)].
Tabeeva GR; Sergeev AV; Gromova SA
Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(9):32-6. PubMed ID: 22027667
[TBL] [Abstract][Full Text] [Related]
16. Agomelatine, a melatonin agonist with antidepressant properties.
Dubovsky SL; Warren C
Expert Opin Investig Drugs; 2009 Oct; 18(10):1533-40. PubMed ID: 19758108
[TBL] [Abstract][Full Text] [Related]
17. [The use of agomelatine (valdoxan) in gambling therapy: a pilot study].
Egorov AY
Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(9):28-31. PubMed ID: 26525811
[TBL] [Abstract][Full Text] [Related]
18. Major depressive disorder, anhedonia and agomelatine: an open-label study.
Di Giannantonio M; Di Iorio G; Guglielmo R; De Berardis D; Conti CM; Acciavatti T; Cornelio M; Martinotti G
J Biol Regul Homeost Agents; 2011; 25(1):109-14. PubMed ID: 21382280
[TBL] [Abstract][Full Text] [Related]
19. Agomelatine: a novel mechanism of antidepressant action involving the melatonergic and the serotonergic system.
San L; Arranz B
Eur Psychiatry; 2008 Sep; 23(6):396-402. PubMed ID: 18583104
[TBL] [Abstract][Full Text] [Related]
20. Circadian rhythms, melatonin and depression.
Quera Salva MA; Hartley S; Barbot F; Alvarez JC; Lofaso F; Guilleminault C
Curr Pharm Des; 2011; 17(15):1459-70. PubMed ID: 21476953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
